Company / EPS (Basic)
Arcadia Biosciences, Inc. EPS (Basic) History
FY2022-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Basic)
-$5.17
FY2025
5-year range
-$27.56 / -$5.17
FY2022-FY2025
Trend
+54.2%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $-27.56 to $-5.17 over the past 3 years.
Based on SEC 10-K filings.
-5.17 in FY2025.
Improved from $-27.56 to $-5.17 over the past 3 years.
EPS (Basic) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, eps (basic) increased 54.2% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 7.60 (safe zone, above 2.9 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Basic)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$5.17 | +54.2% |
| FY2024 | -$11.29 | - |
| FY2023 | - | - |
| FY2022 | -$27.56 | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | - | - |
| FY2017 | - | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026